[2] Frequent recurrences may indicate inadequately controlled diabetes, immunosuppression, antibiotic overuse, concurrent SGLT2 inhibitor therapy, or other underlying health conditions requiring specific management
Nausea affected 42.4% of people on the top dose, compared with 14.8% on placebo, and vomiting affected 25.3%, compared with 4.8%
These compounds work by mimicking hormones that regulate appetite and glucose metabolism, producing significant weight loss primarily through reduced food intake
Short Half-Life, Targeted Potency Unlike IGF1 LR3 , which has a long half-life (2030 hours) and systemic activity, IGFDES has a shorter half-life (2030 minutes) but an intense localized effect
Vitamin K-dependent carboxylation of coagulation factors: insights from a cell-based functional study